CRaTER enrichment for on-target gene editing enables generation of variant libraries in hiPSCs

J Mol Cell Cardiol. 2023 Jun:179:60-71. doi: 10.1016/j.yjmcc.2023.03.017. Epub 2023 Apr 3.

Abstract

Standard transgenic cell line generation requires screening 100-1000s of colonies to isolate correctly edited cells. We describe CRISPRa On-Target Editing Retrieval (CRaTER) which enriches for cells with on-target knock-in of a cDNA-fluorescent reporter transgene by transient activation of the targeted locus followed by flow sorting to recover edited cells. We show CRaTER recovers rare cells with heterozygous, biallelic-editing of the transcriptionally-inactive MYH7 locus in human induced pluripotent stem cells (hiPSCs), enriching on average 25-fold compared to standard antibiotic selection. We leveraged CRaTER to enrich for heterozygous knock-in of a library of variants in MYH7, a gene in which missense mutations cause cardiomyopathies, and recovered hiPSCs with 113 different variants. We differentiated these hiPSCs to cardiomyocytes and show MHC-β fusion proteins can localize as expected. Additionally, single-cell contractility analyses revealed cardiomyocytes with a pathogenic, hypertrophic cardiomyopathy-associated MYH7 variant exhibit salient HCM physiology relative to isogenic controls. Thus, CRaTER substantially reduces screening required for isolation of gene-edited cells, enabling generation of functional transgenic cell lines at unprecedented scale.

Keywords: Cardiomyocytes; Disease modelling; Gene editing; Human induced pluripotent stem cells; Hypertrophic cardiomyopathy; MYH7.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Cardiomyopathies* / metabolism
  • Cardiomyopathy, Hypertrophic* / genetics
  • Cell Line
  • Gene Editing
  • Humans
  • Induced Pluripotent Stem Cells* / metabolism
  • Mutation